Buzzard Pharmaceuticals Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Buzzard Pharmaceuticals General Information

Description

Developer of a pharmaceutical drug designed to be used for cancer treatment. The company is licensed with the rights to develop a recombinant protein, Isunakinra, for cancer indications, and plans to reposition drugs in oncology, enabling medical professionals and organizations to gain further access to cancer indications.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Skeppsbron 16
  • 111 30 Stockholm
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Skeppsbron 16
  • 111 30 Stockholm
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Buzzard Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 22-Nov-2025 Completed Out of Business
2. Later Stage VC 01-Jan-2022 Completed Generating Revenue
1. Later Stage VC 14-Sep-2021 $5.94M $5.94M Completed Clinical Trials - Phase 2
To view Buzzard Pharmaceuticals’s complete valuation and funding history, request access »

Buzzard Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Buzzard Pharmaceuticals’s complete cap table history, request access »

Buzzard Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pharmaceutical drug designed to be used for cancer treatment. The company is licensed with the rights to
Drug Discovery
Stockholm, Sweden
5 As of 2025

Stockholm, Sweden
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Buzzard Pharmaceuticals Competitors (4)

One of Buzzard Pharmaceuticals’s 4 competitors is Swedish Orphan Biovitrum, a Formerly VC-backed company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Swedish Orphan Biovitrum Formerly VC-backed Stockholm, Sweden
Novartis Corporation Basel, Switzerland
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
Cantargia Formerly VC-backed Lund, Sweden
To view Buzzard Pharmaceuticals’s complete competitors history, request access »

Buzzard Pharmaceuticals Patents

Buzzard Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022445159-A1 Inhibitor of interleukin-1 receptor type 1 for use in the treatment of cancer Pending 10-Mar-2022
US-20250188162-A1 Inhibitor of interleukin-1 receptor type 1 for use in the treatment of cancer Pending 10-Mar-2022
WO-2023169686-A1 Inhibitor of interleukin-1 receptor type 1 for use in the treatment of cancer Inactive 10-Mar-2022
ES-2884813-T3 Chimeric cytokine formulations for ocular administration Active 13-Mar-2013
AU-2014243839-A1 Chimeric cytokine formulations for ocular delivery Active 13-Mar-2013 A61K47/10
To view Buzzard Pharmaceuticals’s complete patent history, request access »

Buzzard Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Buzzard Pharmaceuticals FAQs

  • When was Buzzard Pharmaceuticals founded?

    Buzzard Pharmaceuticals was founded in 2016.

  • Where is Buzzard Pharmaceuticals headquartered?

    Buzzard Pharmaceuticals is headquartered in Stockholm, Sweden.

  • What is the size of Buzzard Pharmaceuticals?

    Buzzard Pharmaceuticals has 5 total employees.

  • What industry is Buzzard Pharmaceuticals in?

    Buzzard Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Buzzard Pharmaceuticals a private or public company?

    Buzzard Pharmaceuticals is a Private company.

  • What is Buzzard Pharmaceuticals’s current revenue?

    The current revenue for Buzzard Pharmaceuticals is .

  • How much funding has Buzzard Pharmaceuticals raised over time?

    Buzzard Pharmaceuticals has raised $11.6M.

  • Who are Buzzard Pharmaceuticals’s competitors?

    Swedish Orphan Biovitrum, Novartis, Regeneron Pharmaceuticals, and Cantargia are competitors of Buzzard Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process